The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Texas Tech Univ. v. Spiegelberg
Represented Collegiate Licensing Company in litigation to protect the school colors and verbal trademarks of a Texas-based university. The more
Public-private partnership for private development of a large U.S. public school system
Represented one of the 25 largest U.S. public school systems in a public-private partnership for the private development of public schools. more
Product liability defense for leading pharmaceuticals manufacturer
Served as national counsel for leading pharmaceuticals manufacturer in multi-district litigation and individual product liability lawsuits more
Merger of Pro Brand International Inc.
Represented Pro Brand International, Inc., in its merger with special purpose acquisition company Granahan McCourt Acquisition Corp. (AMEX: GHN). Pro more